The Guideline Development Group focused on Clinical and Diagnostic Specific Middle East respiratory syndrome coronavirus (MERS-CoV) biographies

Overview

For the development of the Clinical and Diagnostic-Specific Guideline for Middle East respiratory syndrome coronavirus (MERS-CoV), a Guideline Development Group (GDG) is being convened, comprising experts with diverse and complementary expertise across multiple specialties and geographic regions. 

The World Health Organization (WHO) technical team coordinated the process of collecting and managing Declarations of Interests (DOIs), which were submitted upon joining the GDG and will be updated at each subsequent meeting. 

WHO gratefully acknowledges the invaluable contributions of all GDG members and extends sincere thanks for their dedication and support in achieving robust, evidence-based recommendations for the clinical management and diagnostic approaches for MERS-CoV.